New Zealand - English - Medsafe (Medicines Safety Authority)

sterling winthrop (nz) ltd (now skb nz or sanofi winthrop) - alexitol sodium 360mg - tablet - 360 mg - active: alexitol sodium 360mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

seven seas ltd - alexitol sodium - oral tablet - 360mg

Ireland - English - HPRA (Health Products Regulatory Authority)

seven seas ltd - alexitol sodium - tablets - 360 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

seven seas ltd - alexitol sodium - tablets - 360 milligram

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

adcock ingram limited - tablet - see ingredients - each tablet contains alexitol sodium 400 mg

United States - English - NLM (National Library of Medicine)

lacorium health international pty ltd - sodium borate (unii: 91mbz8h3qo) (sodium cation - unii:lyr4m0nh37), graphite (unii: 4qqn74lh4o) (graphite - unii:4qqn74lh4o), potassium sulfate (unii: 1k573lc5tv) (potassium cation - unii:295o53k152), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37) - - use on affected areas for relief of itching, irritation, redness, flaking and scaling associated with eczema & psoriasis.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

a. menarini singapore pte. ltd. - sodium polyhydroxyaluminium mono-carbonate hexitol complex -

Australia - English - Department of Health (Therapeutic Goods Administration)

lacorium health international pty ltd - tolnaftate, quantity: 10 mg/g - cream - excipient ingredients: menthol; purified water; glycerol; monobasic sodium phosphate; cetyl alcohol; aloe vera; lavender oil; propylene glycol; urea; dl-alpha-tocopheryl acetate; polysorbate 60; cetostearyl alcohol; benzalkonium chloride; ceteareth-20; white soft paraffin; light liquid paraffin - for the treatment of athlete's foot and ringworm. antifungal action relieves itchy, burning and irritated feet. provides soothing, cooling effect for irritated, painful feet. provides rapid, effective relief of itchy, cracked skin associated with athlete's foot. protects feet from various micro-organisms, bacteria and germs. moisturizes and hydrates dry,cracked, flaky skin.

Australia - English - Department of Health (Therapeutic Goods Administration)

lacorium health international pty ltd - sodium chloride, quantity: 2 mg/g; evening primrose oil, quantity: 0.5 mg/g; d-alpha-tocopheryl acetate, quantity: 2 mg/g; aloe barbadensis, quantity: 0.5 mg/g (equivalent: aloe barbadensis, qty 100 mg/g); lavender oil, quantity: 40 mg/g (equivalent: camphor, qty 0.48 mg/g); borax, quantity: 2 mg/g; potassium sulfate, quantity: 2 mg/g; oatmeal colloidal, quantity: 10 mg/g; chamomile oil german, quantity: 5 mg/g; graphite, quantity: 2 mg/g - cream - excipient ingredients: phenoxyethanol; purified water; cetostearyl alcohol; glycyrrhiza glabra; diazolidinyl urea; light liquid paraffin; ceteareth-20; white soft paraffin; avocado oil

Israel - English - Ministry of Health

alexion pharma israel ltd - eculizumab - concentrate for solution for infusion - eculizumab 10 mg/ml - eculizumab - eculizumab - soliris is indicated for the treatment of patients with: - paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history. eculizumab has not been studied in clinical trials in patients with pnh below 11 years of age.- atypical haemolytic uremic syndrome (ahus).soliris is indicated in adults for the treatment of: - refractory generalized myasthenia gravis (gmg) in patients who are anti-acetylcholine receptor (achr) antibody-positive.-neuromyelitis optica spectrum disorder (nmosd) in patients who are anti-aquaporin-4 (aqp4) antibody-positive with a relapsing course of the disease who have received prior therapy.